Bladder Cancer Clinical Trials | Norton Healthcare Louisville, Ky.

Bladder Cancer and Urothelial Cancer Clinical Trials

Norton Cancer Institute is at the forefront of cancer treatment research. As principal investigators on numerous trials, our specialist physicians have access to innovative treatments and numerous bladder cancer clinical trials.

Learn more about participating in a clinical trial at Norton Healthcare.

Active bladder cancer and urothelial cancer clinical trials include:

Genitourinary Cancer

A phase III, multicenter, randomized, placebo-controlled, double-blind study of atezolizumab (anti-pd-l1 antibody) in combination with gemcitabine/carboplatin versus gemcitabine/carboplatin alone in patients with untreated locally advanced or metastatic u

Genitourinary Cancer

A Phase 3 Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Selected FGFR Gene Aberrations

Genitourinary Cancer

A Phase Ib/II Open Label, Multicenter, Randomized Umbrella Study Evaluating The Efficacy And Safety Of Multiple Immunotherapy-Based Treatment Combinations In Patients With Locally Advanced Or Metastatic Urothelial Carcinoma After Failure With Platinum-Con

Genitourinary Cancer

A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma

Genitourinary Cancer

A Phase III, Randomized, Open-Label, Multi-Center, Global Study to Determine the Efficacy and Safety of Durvalumab in Combination with Gemcitabine+Cisplatin for Neoadjuvant Treatment Followed by Durvalumab Alone for Adjuvant Treatment in Patients with Mus

Genitourinary Cancer

A Phase III, Randomized, Open Label, Controlled, Multi-Center, Global Study of First-Line Durvalumab in Combination with Standard of Care Chemotherapy and Durvalumab in Combination with Tremelimumab and Standard of Care Chemotherapy Versus Standard of Car

Genitourinary Cancer

An open-label multi-cohort Phase 1b/2 study of derazantinib and atezolizumab in patients with urothelial cancer expressing activating molecular FGFR aberrations (FIDES-02)

Genitourinary Cancer

A Phase 3, Randomized, Double-blind, Placebo-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) versus CRT Alone in Participants with Muscle-invasive Bladder Cancer (MIBC) (KEY

Cancer – 4673

Appointments

Cancer care that isn’t too far from home.

(502) 629-HOPE (4673)


Request an Appointment Online

Clinical trials

Clinical Trials

Learn more about clinical trials at Norton Healthcare
(502) 629-3500

Over age 26? You may be eligible for the HPV vaccine

Over the age of 26? You still may be able to get the HPV vaccine. What is HPV? The human papillomavirus (HPV) is the most common sexually transmitted infection (STI). HPV is not the same […]

Read Full Story

Brain cancer doesn’t stop for the pandemic; it didn’t stop for Ben Smith

A seizure in late May, followed by another in early June led Ben Smith to the emergency department at Norton Women’s & Children’s Hospital. Visitor restrictions were in place due to the coronavirus pandemic, but […]

Read Full Story

While we’re all trying to stay safe at home, Cologuard is a colonoscopy alternative

If you’ve been trying to stay home more and are putting off your colonoscopy, consider Cologuard or a fecal immunochemical test (FIT) to catch colon cancer early while it’s still very treatable. A colonoscopy is […]

Read Full Story

UVB light as a treatment for cutaneous lymphoma

Ultraviolet light, specifically, narrowband UVB light, can reduce skin inflammation, especially as a treatment for eczema and psoriasis. A Louisville-area dermatologist is using this therapy as a treatment for cutaneous T-cell lymphoma, a blood cell […]

Read Full Story

Back from stage 3 ovarian cancer, Stephanie Virgin is a mom and thriving professional

Photo by Anna May Photography Stephanie Virgin was 29 and hoping to start a family, so ovarian cancer was the last thing on her mind — even when she experienced textbook symptoms. The Louisville native […]

Read Full Story
Related Stories

Over age 26? You may be eligible for the HPV vaccine

Over the age of 26? You still may be able to get the HPV vaccine. What is HPV? The human papillomavirus (HPV) is the most common sexually transmitted infection (STI). HPV is not the same […]

Read Full Story

Brain cancer doesn’t stop for the pandemic; it didn’t stop for Ben Smith

A seizure in late May, followed by another in early June led Ben Smith to the emergency department at Norton Women’s & Children’s Hospital. Visitor restrictions were in place due to the coronavirus pandemic, but […]

Read Full Story

While we’re all trying to stay safe at home, Cologuard is a colonoscopy alternative

If you’ve been trying to stay home more and are putting off your colonoscopy, consider Cologuard or a fecal immunochemical test (FIT) to catch colon cancer early while it’s still very treatable. A colonoscopy is […]

Read Full Story

UVB light as a treatment for cutaneous lymphoma

Ultraviolet light, specifically, narrowband UVB light, can reduce skin inflammation, especially as a treatment for eczema and psoriasis. A Louisville-area dermatologist is using this therapy as a treatment for cutaneous T-cell lymphoma, a blood cell […]

Read Full Story

Back from stage 3 ovarian cancer, Stephanie Virgin is a mom and thriving professional

Photo by Anna May Photography Stephanie Virgin was 29 and hoping to start a family, so ovarian cancer was the last thing on her mind — even when she experienced textbook symptoms. The Louisville native […]

Read Full Story

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.